About 112,000 results
Open links in new tab
  1. A Medicine Company | Eli Lilly and Company

    Lilly is a medicine company that puts health above all. Learn about our medicines, view condition support, find care, and much more.

  2. Current Lilly Medicines & Diagnostics | Eli Lilly and Company

    Find a list of current Lilly medicines, and filter by commonly prescribed, most recently available, and therapeutic area.

  3. Contact us - Eli Lilly and Company

    We're here to answer questions related to Lilly medicines, devices or other inquiries.

  4. Find Your Career with Eli Lilly | Lilly Careers

    Find your place at Lilly. For more than a century, we have united caring with discovery to make life better.

  5. Zepbound® (tirzepatide) Injection for Adults with Obesity or OSA

    The purpose of this registry is to collect information about the health of you and your baby. Talk to your healthcare provider about how you can take part in this registry, or you may contact Lilly …

  6. Savings Card, Cost & Coverage Support | Zepbound® (tirzepatide)

    As described above, Lilly provides a tool to help you determine if your insurance covers Zepbound and provides other savings options if it doesn’t. You may also use the links below to learn …

  7. About Us | Eli Lilly and Company

    Find your place at Lilly If you're ready to challenge the status quo and advance medicine—all in the name of health—join us. We need your help to do things that have never been done.

  8. es.lilly.com - Bienvenidos

    Sitio web donde buscar información médica sobre los productos de Lilly, fichas técnicas y respuestas a preguntas más frecuentes sobre las plumas y dispositivos de administración de …

  9. Health Above All | A Medicine Company | Eli Lilly and Company

    The camera cuts to the woman's back, bra unstrapped. Text appears on the screen reading, "is in your hands." The camera cuts to the woman's bra off. Text appears on the screen reading, …

  10. Press Releases | News | Eli Lilly and Company

    Nov 3, 2025 · Lilly's selective amylin agonist, eloralintide, demonstrated meaningful weight loss and favorable tolerability in a Phase 2 study of adults with obesity or overweight